dihexa administration route (PNB-0408) | c-Met/HGFR Activator DIHEXA | Peptide Synthetic |

Severe hypokalaemia (low blood potassium) is rare but can develop in some cases, particularly in severe megaloblastic anaemia or in patients taking certain medications such as diuretics

For the broader recovery protocol, compare BPC-157 with other healing and recovery peptides, and see KPV for the anti-inflammatory addition

Atrophic scars are depressions in the skin, the most common type from inflammatory acne

Fabricados bajo cGMP con certificado de anlisis

BPC-157 Peptide Formulation Details BPC-157 Peptide Formulation Details This BPC-157 peptide for sale is supplied as a lyophilised powder the preferred format for maintaining peptide stability in research settings